Gene patent ruling hurts Myriad but not fatally- MSN Money
No, private companies, you can’t slap a patent on genes that occur in nature.
You can, however, hold exclusive rights to any Frankensteined gene that comes out of your lab. That’s the leeway the Supreme Court offered on Thursday when it handed down its decision in Association for Molecular Pathology vs. Myriad Genetics (MYGN -5.63%),